Abstract
Objectives
Motoric cognitive risk syndrome (MCR) is a newly described pre-dementia syndrome characterized by cognitive complaints and slow gait and is associated with numerous adverse outcomes. Previous studies have indicated an association between C-reactive protein (CRP) and cognitive decline, but no clear relationship between CRP and MCR has been reported. The purpose of the study is to examine the associations between CRP with MCR and MCR subtypes.
Methods
Participants were 5,642 adults aged ≥60 years from the China Health and Retirement Longitudinal Study (CHARLS). MCR was defined as cognitive complaints and slow gait speed without dementia or impaired mobility. Two subtypes of MCR were defined by whether memory impairment (MI) was also present, such as MCR-MI and MCR-non-MI. MI was evaluated through the immediate recall and delayed recall in a word recall test during the CHARLS and was defined as 1.0 standard deviation or more below the mean values of the test scores in this cohort.
Results
Of the participants, 421 (7.46%) met the criteria for MCR. After multivariate adjustment, participants with higher CRP levels had an increased likelihood of MCR (fourth quartile: adjusted odds ratio [OR]=1.44; 95% confidence interval [CI]: 1.06–1.95) compared with those in the first quartile group. The OR for MCR-MI was 2.04 (95% CI: 1.35–3.09) for the highest quartile of CRP compared to the lowest quartile. No significant associations between CRP levels and odds of MCR-non-MI were observed.
Conclusions
Higher CRP levels were associated with increased odds of prevalent MCR-MI but not MCR-non-MI among community-dwelling older adults.
Similar content being viewed by others
References
Hardeland, R. Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. International journal of molecular sciences 2019;20(5). https://doi.org/10.3390/ijms20051223
Jia, L, Quan, M, Fu, Y, et al. Dementia in China: epidemiology, clinical management, and research advances. The Lancet Neurology 2020;19(1):81–92. https://doi.org/10.1016/S1474-4422(19)30290-X
Verghese, J, Annweiler, C, Ayers, E, et al. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology 2014;83(8):718–726. https://doi.org/10.1212/WNL.0000000000000717
Shim, H, Kim, M, Won, CW. Motoric Cognitive Risk Syndrome Using Three-Item Recall Test and Its Associations with Fall-Related Outcomes: The Korean Frailty and Aging Cohort Study. International journal of environmental research and public health 2020;17(10). https://doi.org/10.3390/ijerph17103364
Doi, T, Shimada, H, Makizako, H, et al. Motoric Cognitive Risk Syndrome: Association with Incident Dementia and Disability. Journal of Alzheimer’s disease: JAD 2017;59(1):77–84. https://doi.org/10.3233/JAD-170195
Sekhon, H, Allali, G, Beauchet, O. Motoric cognitive risk syndrome and cardiovascular diseases and risk factors in the Canadian population: Results from the baseline assessment of the Canadian longitudinal study on aging. Archives of gerontology and geriatrics 2019;85:103932. https://doi.org/10.1016/j.archger.2019.103932
Beauchet, O, Sekhon, H, Launay, CP, et al. Motoric cognitive risk syndrome and mortality: results from the EPIDOS cohort. European journal of neurology 2019;26(5):794–e756. https://doi.org/10.1111/ene.13891
Schmidt-Arras, D, Rose-John, S. IL-6 pathway in the liver: From physiopathology to therapy. Journal of hepatology 2016;64(6):1403–1415. https://doi.org/10.1016/j.jhep.2016.02.004
McKhann, GM, Knopman, DS, Chertkow, H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association 2011;7(3):263–269. https://doi.org/10.1016/j.jalz.2011.03.005
Duong, T, Nikolaeva, M, Acton, PJ. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer’s disease. Brain research 1997;749(1):152–156. https://doi.org/10.1016/s0006-8993(96)01359-5
Iwamoto, N, Nishiyama, E, Ohwada, J, et al. Demonstration of CRP immunoreactivity in brains of Alzheimer’s disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neuroscience letters 1994;177(1–2):23–26. https://doi.org/10.1016/0304-3940(94)90035-3
Schmidt, R, Schmidt, H, Curb, JD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Annals of neurology 2002;52(2):168–174. https://doi.org/10.1002/ana.10265
Xu, G, Zhou, Z, Zhu, W, et al. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment. Journal of the neurological sciences 2009;284(1–2):77–80. https://doi.org/10.1016/j.jns.2009.04.018
Darweesh, SKL, Wolters, FJ, Ikram, MA, et al. Inflammatory markers and the risk of dementia and Alzheimer’s disease: A meta-analysis. Alzheimer’s & dementia: the journal of the Alzheimer’s Association 2018;14(11):1450–1459. https://doi.org/10.1016/j.jalz.2018.02.014
O’Bryant, SE, Waring, SC, Hobson, V, et al. Decreased C-reactive protein levels in Alzheimer disease. Journal of geriatric psychiatry and neurology 2010;23(1):49–53. https://doi.org/10.1177/0891988709351832
Nilsson, K, Gustafson, L, Hultberg, B. C-reactive protein level is decreased in patients with Alzheimer’s disease and related to cognitive function and survival time. Clinical biochemistry 2011;44(14–15):1205–1208. https://doi.org/10.1016/j.clinbiochem.2011.07.011
Nilsson, K, Gustafson, L, Hultberg, B. C-reactive protein: vascular risk marker in elderly patients with mental illness. Dementia and geriatric cognitive disorders 2008;26(3):251–256. https://doi.org/10.1159/000160957
Gong, C, Wei, D, Wang, Y, et al. A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease. American journal of Alzheimer’s disease and other dementias 2016;31(3):194–200. https://doi.org/10.1177/1533317515602087
Park, JK, Lee, KJ, Kim, JY, et al. The Association of Blood-Based Inflammatory Factors IL-1β, TGF-β and CRP with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Psychiatry investigation 2021;18(1):11–18. https://doi.org/10.30773/pi.2020.0205
Engelhart, MJ, Geerlings, MI, Meijer, J, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Archives of neurology 2004;61(5):668–672. https://doi.org/10.1001/archneur.61.5.668
Licastro, F, Pedrini, S, Caputo, L, et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer’s disease: peripheral inflammation or signals from the brain? Journal of neuroimmunology 2000;103(1):97–102. https://doi.org/10.1016/s0165-5728(99)00226-x
Sousa, AC, Zunzunegui, MV, Li, A, et al. Association between C-reactive protein and physical performance in older populations: results from the International Mobility in Aging Study (IMIAS). Age and ageing 2016;45(2):274–280. https://doi.org/10.1093/ageing/afv202
Taaffe, DR, Harris, TB, Ferrucci, L, et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. The journals of gerontology Series A, Biological sciences and medical sciences 2000;55(12):M709–715. https://doi.org/10.1093/gerona/55.12.m709
Felicio, DC, Pereira, DS, Assumpção, AM, et al. Inflammatory mediators, muscle and functional performance of community-dwelling elderly women. Archives of gerontology and geriatrics 2014;59(3):549–553. https://doi.org/10.1016/j.archger.2014.08.004
Legrand, D, Adriaensen, W, Vaes, B, et al. The relationship between grip strength and muscle mass (MM), inflammatory biomarkers and physical performance in community-dwelling very old persons. Archives of gerontology and geriatrics 2013;57(3):345–351. https://doi.org/10.1016/j.archger.2013.06.003
Sonnega, A, Faul, JD, Ofstedal, MB, et al. Cohort Profile: the Health and Retirement Study (HRS). International journal of epidemiology 2014;43(2):576–585. https://doi.org/10.1093/ije/dyu067
Zhang, L, Feng, BL, Wang, CY, et al. Prevalence and factors associated with motoric cognitive risk syndrome in community-dwelling older Chinese: a cross-sectional study. European journal of neurology 2020;27(7):1137–1145. https://doi.org/10.1111/ene.14266
Liu, X, Yu, Y, Zhu, S. Inflammatory markers in postoperative delirium (POD) and cognitive dysfunction (POCD): A meta-analysis of observational studies. PloS one 2018;13(4):e0195659. https://doi.org/10.1371/journal.pone.0195659
Laurin, D, David Curb, J, Masaki, KH, et al. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiology of aging 2009;30(11):1724–1727. https://doi.org/10.1016/j.neurobiolaging.2008.01.008
Komulainen, P, Lakka, TA, Kivipelto, M, et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age and ageing 2007;36(4):443–448. https://doi.org/10.1093/ageing/afm051
Schram, MT, Euser, SM, de Craen, AJ, et al. Systemic markers of inflammation and cognitive decline in old age. Journal of the American Geriatrics Society 2007;55(5):708–716. https://doi.org/10.1111/j.1532-5415.2007.01159.x
Watanabe, Y, Kitamura, K, Nakamura, K, et al. Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST). Dementia and geriatric cognitive disorders extra 2016;6(1):10–19. https://doi.org/10.1159/000442585
Alley, DE, Crimmins, EM, Karlamangla, A, et al. Inflammation and rate of cognitive change in high-functioning older adults. The journals of gerontology Series A, Biological sciences and medical sciences 2008;63(1):50–55. https://doi.org/10.1093/gerona/63.1.50
Dik, MG, Jonker, C, Hack, CE, et al. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005;64(8):1371–1377. https://doi.org/10.1212/01.WNL.0000158281.08946.68
Heneka, MT, Carson, MJ, El Khoury, J, et al. Neuroinflammation in Alzheimer’s disease. The Lancet Neurology 2015;14(4):388–405. https://doi.org/10.1016/S1474-4422(15)70016-5
Di Napoli, M, Papa, F. C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology? Circulation 2005;112(6):781–785. https://doi.org/10.1161/CIRCULATIONAHA.104.516237
Wang, A, Liu, J, Li, C, et al. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease. Journal of the American Heart Association 2017;6(10). https://doi.org/10.1161/JAHA.117.005610
Dong, Y, Wang, X, Zhang, L, et al. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study. Journal of epidemiology and community health 2019;73(2):188–192. https://doi.org/10.1136/jech-2018-211433
Wang, Z, Wang, X, Chen, Z, et al. Distribution of High-Sensitivity C-Reactive Protein and Its Relationship with Other Cardiovascular Risk Factors in the Middle-Aged Chinese Population. International journal of environmental research and public health 2016;13(9). https://doi.org/10.3390/ijerph13090872
Gorelick, PB, Scuteri, A, Black, SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42(9):2672–2713. https://doi.org/10.1161/STR.0b013e3182299496
Cesari, M, Penninx, BW, Pahor, M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. The journals of gerontology Series A, Biological sciences and medical sciences 2004;59(3):242–248. https://doi.org/10.1093/gerona/59.3.m242
Gonzalez-Freire, M, de Cabo, R, Studenski, SA, et al. The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle. Frontiers in aging neuroscience 2014;6:208. https://doi.org/10.3389/fnagi.2014.00208
Funding
Funding: This work was supported by the PLA General Hospital youth funding Grant No.QNF19033.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest: None.
Ethical standards: The study was approved by Ethical Review Committee of Peking University which required informed consent to be obtained.
Rights and permissions
About this article
Cite this article
Bai, A., Shi, H., Huang, X. et al. Association of C-Reactive Protein and Motoric Cognitive Risk Syndrome in Community-Dwelling Older Adults: The China Health and Retirement Longitudinal Study. J Nutr Health Aging 25, 1090–1095 (2021). https://doi.org/10.1007/s12603-021-1678-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-021-1678-3